Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI and telemedicine could help nursing homes in doctor shortages

NCT ID NCT04679181

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed pilot study looked at whether nursing home staff in areas with few doctors would accept using artificial intelligence and telemedicine to help care for elderly residents. The study involved 137 participants aged 65 and older living in nursing homes located in medical deserts. The goal was to measure how often nurses used the AI/telemedicine system instead of usual care, and to compare delays in getting medical advice and rates of unplanned hospitalizations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telemedicine and artificial intelligence
What this could lead to
If successful, this could show that AI and telemedicine are practical tools to help nursing homes in remote areas get faster medical advice.
What could go wrong
This is a small pilot study, so results may not apply to all nursing homes. It only measures acceptability, not whether it improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

137 people

The number who actually took part.

Started

Dec 2020

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient older than 65 years old. * Patient living in Nursing Home located in medical desert. * Patient presenting symptoms involved medical doctor call. * Patient or legal representative having signed consent form * Patient covered by social security Exclusion Criteria: * End of life patient. * Chronic aphasic patient.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Homes for the aged are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • EHPAD Ernest Coulaud

    Peyrelevade, 19290, France

  • EHPAD J et M Colaud

    Saint-Privat, 19220, France

  • EHPAD La Porte d'Aquitaine

    La Roche-Chalais, 24490, France

  • EHPAD Le Bois Joli

    Auzances, 23700, France

  • EHPAD Le Chant des Rivières

    Chambon-sur-Voueize, 23170, France

  • Ehpad Le Chavanon

    Merlines, 19340, France